Harmony Biosciences Holdings (HRMY)

Operating return on assets (Operating ROA)

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020
Operating income (ttm)	US$ in thousands	192,030	199,447	146,839	133,053	120,186	101,204	110,356	100,552	87,529	66,656	55,983
Total assets	US$ in thousands	811,448	777,766	760,183	715,092	673,870	643,464	505,034	464,005	433,443	391,092	359,695	337,252	427,074	320,073
Operating ROA		23.67%	25.64%	19.32%	18.61%	17.84%	15.73%	21.85%	21.67%	20.19%	17.04%	15.56%

December 31, 2023 calculation

Operating ROA = Operating income (ttm) ÷ Total assets
= $192,030K ÷ $811,448K
= 23.67%

Harmony Biosciences Holdings Inc's operating return on assets (operating ROA) has shown a generally positive trend over the past eight quarters. The company's operating ROA ranged from 15.73% to 25.64% during this period, indicating its ability to generate operating income relative to its total assets.

The highest operating ROA was observed in Q3 2023 at 25.64%, suggesting that the company efficiently utilized its assets to generate operating profits during that quarter. This may have been driven by effective management of expenses or higher revenues compared to the assets employed.

Overall, the company's operating ROA has been consistently above 15%, with an average of approximately 20% over the eight quarters analyzed. This indicates that Harmony Biosciences Holdings Inc has been relatively effective in generating operating income in relation to its asset base, which is a positive indication of operational efficiency and profitability.